Status:
COMPLETED
Understanding the Impact of Cartridge-Based Electronic Cigarettes and Generated Aerosols on Cardiopulmonary Health
Lead Sponsor:
Virginia Commonwealth University
Conditions:
E-Cig Use
Eligibility:
All Genders
21+ years
Phase:
EARLY_PHASE1
Brief Summary
Over the last decade, e-cigarettes have become increasingly popular, due to their promotion as a healthy alternative to traditional tobacco cigarettes. However, there are large discrepancies of knowle...
Eligibility Criteria
Inclusion
- E-Cigarette group:
- 21 years of age or older
- Used e-cigarettes (≥3 times/week for ≥3 months)
- Non e-cigarette group
- ● 21 years of age or older
Exclusion
- 20 years old and younger
- Use of cigarettes for 15 days or more in the past 60 days
- Use of other tobacco products (cigars, hookah, smokeless) weekly or more frequently in the past 60 days
- Use of marijuana or any illicit or prescription drugs for non-medical use weekly or more frequently in the past 60 days
- Known allergy to propylene glycol or vegetable glycerin
- Evidence of cardiovascular, pulmonary, renal, hepatic, metabolic, or cerebral diseases
- Disorder or use of medication that affects cardiopulmonary health
- Evidence of pregnancy or current nursing
Key Trial Info
Start Date :
January 10 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 30 2024
Estimated Enrollment :
4 Patients enrolled
Trial Details
Trial ID
NCT05199480
Start Date
January 10 2022
End Date
July 30 2024
Last Update
July 1 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Virginia Commonwealth University
Richmond, Virginia, United States, 23298